## Anticholinergic Bronchodilators: Properties and Clinical Use ### M3 Receptor Blockade and Duration **Key Point:** Tiotropium is a long-acting muscarinic antagonist (LAMA) that selectively blocks M3 receptors on airway smooth muscle. It has a duration exceeding 24 hours, permitting once-daily dosing. This statement is **correct**. [cite:KD Tripathi 8e Ch 17] ### Efficacy in COPD **High-Yield:** Anticholinergics are particularly effective in COPD because: - COPD involves **excessive vagal tone** and acetylcholine-mediated bronchoconstriction - Blocking M3 receptors prevents this cholinergic-driven airway narrowing - They also reduce mucus secretion (M3 on goblet cells) This statement is **correct**. ### Onset of Action: Critical Distinction **Warning:** This is the key trap. **Anticholinergics have a SLOWER onset than beta-2 agonists:** - **Beta-2 agonists:** onset 5–15 minutes (inhaled) - **Anticholinergics:** onset 30–60 minutes Therefore, **anticholinergics are NOT preferred for acute bronchospasm**. SABAs (salbutamol) are the first-line agent for acute relief. This statement is **INCORRECT**. ### Combination Therapy in Acute Exacerbations **Clinical Pearl:** In acute COPD exacerbations, ipratropium (short-acting anticholinergic) is combined with beta-2 agonists (e.g., salbutamol) to: - Provide rapid relief from the SABA - Add additional bronchodilation from the anticholinergic - Achieve synergistic effect This statement is **correct**. ## Comparison: Onset and Use Context | Property | Beta-2 Agonists | Anticholinergics | | --- | --- | --- | | **Onset** | 5–15 min (inhaled) | 30–60 min | | **Duration** | SABA: 4–6 hr; LABA: 12–24 hr | SAMA: 4–6 hr; LAMA: >24 hr | | **Acute relief** | ✓ First-line | ✗ Too slow | | **Maintenance** | ✓ Effective | ✓ Effective (esp. COPD) | | **Mechanism** | ↑ cAMP | Block M3 receptors | **Mnemonic:** **ANTICHOLINERGICS ARE SLOW** — **A**nticholinergics **A**re **S**low (remember: 30–60 min onset). Never use as first-line for acute attacks. **Tip:** In exam questions, when you see "acute bronchospasm relief," think **SABA first**. Anticholinergics are adjuncts in acute exacerbations (combined therapy) or maintenance agents, not primary acute relievers.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.